Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-11

Clinical Trial Update: Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

View source ↗

Summary

A real-world Spanish cohort study reports on the effectiveness, safety, and clinical outcomes of elbasvir/grazoprevir for hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elbasvir/Grazoprevir (elbasvir/grazoprevir)

Snippet

Sponsor: Hepa C | Conditions: Hepatitis C | Status: COMPLETED